Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for Biofrontera (BFRI) over the last 5 years, with Q3 2025 value amounting to -$0.62.

  • Biofrontera's EPS (Weighted Average and Diluted) rose 3673.47% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 33281.25%. This contributed to the annual value of -$3.22 for FY2024, which is 7527.38% up from last year.
  • Biofrontera's EPS (Weighted Average and Diluted) amounted to -$0.62 in Q3 2025, which was up 3673.47% from -$0.57 recorded in Q2 2025.
  • Biofrontera's EPS (Weighted Average and Diluted)'s 5-year high stood at $4.55 during Q4 2023, with a 5-year trough of -$7.23 in Q2 2023.
  • Over the past 5 years, Biofrontera's median EPS (Weighted Average and Diluted) value was -$0.76 (recorded in 2022), while the average stood at -$1.52.
  • The largest annual percentage gain for Biofrontera's EPS (Weighted Average and Diluted) in the last 5 years was 26250.0% (2023), contrasted with its biggest fall of 185053.37% (2023).
  • Quarter analysis of 5 years shows Biofrontera's EPS (Weighted Average and Diluted) stood at -$2.0 in 2021, then tumbled by 40.0% to -$2.8 in 2022, then soared by 262.5% to $4.55 in 2023, then plummeted by 105.56% to -$0.25 in 2024, then crashed by 144.99% to -$0.62 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.62 for Q3 2025, versus -$0.57 for Q2 2025 and -$0.47 for Q1 2025.